Poxvirus as a vector to transduce human dendritic cells for immunotherapy: Abortive infection but reduced APC function

Gene Therapy

Volumn 7, Issue 18, 2000, Pages 1575-1583

  Jenne, L ^a,b   Hauser, C ^b,c   Arrighi, J F ^b,c   Saurat, J H ^b   Hugin A W ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Department of Dermatology DHURDV ^*  (Switzerland)

^c UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Dendritic Cells; Gene therapy; Immunotherapy; Poxvirus; Vaccinia virus; Viral vector

Indexed keywords

B7 ANTIGEN; BETA GALACTOSIDASE; CD83 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GREEN FLUORESCENT PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MEMBRANE ANTIGEN; VIRUS VECTOR;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; FIBROBLAST CULTURE; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; INFECTION RATE; MIXED LYMPHOCYTE REACTION; PHENOTYPE; POXVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD80; BETA-GALACTOSIDASE; DENDRITIC CELLS; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOGLOBULINS; IMMUNOTHERAPY; LUMINESCENT PROTEINS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MEMBRANE GLYCOPROTEINS; PROMOTER REGIONS (GENETICS); TRANSFECTION; VACCINIA VIRUS;

DNA VIRUSES; POXVIRIDAE; VACCINIA; VACCINIA VIRUS;

EID: 0033772859     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301287     Document Type: Article

References (68)

1. Dendritic cells and the control of immunity
2. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products
3. Long-term culture of human CD34+ progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34-CD14- and a CD34-CD14+ dendritic cell precursor
4. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
5. Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
6. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells
7. Rapid extracellular degradation of synthetic class I peptides by human dendritic cells
8. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3
9. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
10. Nonviral transfection of distinct types of human dendritic cells: High-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells
11. A comparison of gene transfer methods in human dendritic cells
12. Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors
13. High efficiency adenovirus-mediated gene transfer to human dendritic cells
14. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens
15. Applications of pox virus vectors to vaccination: An update
16. Poxviruses as expression vectors
17. Nonreplicating vaccinia vector efficiently expresses recombinant genes
18. NYVAC: A highly attenuated strain of vaccinia virus
19. Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression
20. Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases
21. Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate
22. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
23. Inhibition of dendritic cell maturation by herpes simplex virus
24. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells
25. IFN-gamma inhibits double-stranded RNA-induced E-selectin expression in human endothelial cells
26. Double-stranded RNA-induced inducible nitric-oxide synthase expression and interleukin-1 release by murine macrophages requires NF-kappaB activation
27. Dendritic cells are potent antigen-presenting cells for microbial superantigens
28. Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus
29. Vaccinia virus inhibits the maturation of human dendritic cells: A novel mechanism of immune evasion
30. Heterogeneity of biologic responses of melanoma-specific CTL
31. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells
32. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells
33. Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors
34. Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes
35. Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors
36. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
37. Mature dendritic cells infected with Herpes simplex virus type I are inhibited in their T-cell stimulatory capacity
38. Dendritic cells as adjuvants for immune-mediated resistance to tumors
39. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity
40. Cultured blood dendritic cells retain HIV-1 antigen-presenting capacity for memory CTL during progressive HIV-1 infection
41. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
42. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
43. Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C
44. Viral immune evasion due to persistence of activated T cells without effector function
45. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge
46. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
47. Role of lymphokine-secreting CD8+ T cells in cytotoxic T lymphocyte responses against vaccinia virus
48. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors
49. The central role of CD4+ T cells in the antitumor immune response
50. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells
51. CD4 T cells and their role in antitumor immune responses
52. Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use
53. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
54. Enhancement of MHC class I-restricted peptidespecific T cell induction by a DNA prime/MVA boost vaccination regime
55. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells
56. Antiviral immune responses in CTLA4 transgenic mice
57. Immune responses in the absence of costimulation: Viruses know the trick
58. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo
59. Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells
60. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells
61. Poxviridae: The virus and their replication
62. Vaccinia virus immune evasion
63. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions
64. Structure of vaccinia virus early promoters
65. Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes
66. Compact, synthetic, vaccinia virus early/late promoter for protein expression
67. Green fluorescent protein expressed by a recombinant vaccinia virus permits early detection of infected cells by flow cytometry
68. Expression of proteins in mammalian cells using vaccinia virus vectors